Glun2B and mGLU5 are typically upregulated in neurodegenerative diseases, and likely contribute to cognitive dysfunction and excitotoxicity through enhanced glutamatergic neurotransmission [105-106]. Here, GRM5 is linked to neurodegenerative disease.